NCT02329106View on ClinicalTrials.gov

Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 1, 2014

Primary Completion Date

December 1, 2020

Study Completion Date

January 1, 2021

Conditions
Liver Cancer
Interventions
DEVICE

Irreversible electroporation (IRE)

Irreversible electroporation (IRE) is a new, minimal-invasive image-guided treatment method for tumors not amenable for surgical resection or thermal ablation, due to vicinity near vital structures such as vessels,bile ducts and diaphragmatic dome.

Trial Locations (1)

510665

FUDA Cancer Hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02329106 - Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome | Biotech Hunter | Biotech Hunter